MAULANA AZAD MEDICAL COLLEGE

Aethlon Medical reports Q2 FY2024 financials, highlights progress in oncology trials in Australia and India, including enrollment of first two patients in Hemopurifier® cancer trial. Company implements cost-cutting measures, appoints James Frakes as permanent CEO, and maintains cash balance of $6.9 million. Conference call scheduled for November 13, 2024.

Delhi govt extends tenure of regular and ad-hoc Senior and Junior Residents in hospitals until ongoing recruitment process completion by a Centralised Committee, aiming to stabilize workforce and ensure patient care.